المؤلفون: Yan Zhou, Mei Li, Bing Zhang, Cheng Yang, Yaling Wang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Jianjun Zhang, Xiaoshuang Li, Qingcheng Yang, Haiyan Hu, Yang Yao

المصدر: BMC Medicine, Vol 21, Iss 1, Pp 1-11 (2023)

مصطلحات موضوعية: Cell-based immunotherapy, MASCT-I, Camrelizumab, Apatinib, Sarcoma, Medicine

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1741-7015

URL الوصول: https://doaj.org/article/34e30e3ccc2841818b381fefbac782d7

المؤلفون: Yan Zhou, Mei Li, Bing Zhang, Cheng Yang, Yaling Wang, Shuier Zheng, Lina Tang, Chenliang Zhou, Guowei Qian, Yujing Huang, Wenxi Yu, Hongtao Li, Yonggang Wang, Aina He, Zan Shen, Jianjun Zhang, Xiaoshuang Li, Qingcheng Yang, Haiyan Hu, Yang Yao

مصطلحات موضوعية: Immunology, Cell-based immunotherapy, MASCT-I, Camrelizumab, Apatinib, Sarcoma

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_pilot_study_of_multi-antigen_stimulated_cell_therapy-I_plus_camrelizumab_and_apatinib_in_patients_with_advanced_bone_and_soft-tissue_sarcomas/24669876

الاتاحة: https://doi.org/10.6084/m9.figshare.24669876.v1
https://figshare.com/articles/journal_contribution/Additional_file_1_of_A_pilot_study_of_multi-antigen_stimulated_cell_therapy-I_plus_camrelizumab_and_apatinib_in_patients_with_advanced_bone_and_soft-tissue_sarcomas/24669876